Ameliorating post-infarction myocardial fibrosis and cardiac function via ROS-responsive hydrogel-mediated IL-11 antibody delivery
Myocardial fibrosis, driven by fibroblast activation following myocardial infarction (MI), represents a significant pathological process contributing to heart failure progression. Interleukin-11 (IL-11) is recognized as a key mediator in fibrotic pathologies across multiple organs, including the hea...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Communications Co., Ltd.
2026-06-01
|
| Col·lecció: | Bioactive Materials |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2452199X26000423 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
